drugset / Trial / NCT02214095

Glucosamine Periodontal Adjunctive Therapy

NCT02214095

Phase 0 Terminated 40 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is the first evidence based work evaluated the systemic use of glucosamine as an adjunctive therapy to closed mechanical debridement in chronic periodontitis. The use of glucosamine sulphate was correlated with clinical outcomes and IL1-β level in the GCF of patients with moderate to advanced chronic periodontitis

Timeline

Start
2012-01
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glucosamine Small molecule 500 mg

Indications